UPDATED: Chicago makes second run at Allergan, J – J, Purdue and others with painkiller lawsuit #top #generic #drug #companies

Posted On May 18 2017 by

#chicago pharmaceutical companies # UPDATED: Chicago makes second run at Allergan, J J, Purdue and others with painkiller lawsuit Opioid makers thought they had dodged a litigation bullet 6 months ago when a federal judge dismissed a lawsuit by the City of Chicago trying to hold them accountable for an “epidemic” of painkiller, and even heroin, abuse. But the city is being tenacious and has refiled lawsuits claiming 6 drugmakers overstated the claims of the drugs’ benefits while downplaying their risks. The second amended complaint was filed on Thursday in Chicago against Purdue Pharma, Teva Pharmaceutical Industries ($TEVA), Johnson Johnson’s …


UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ #global #pharmaceutical #industry

Posted On May 13 2017 by

#sankyo pharma # UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ Times have been tough for Daiichi Sankyo, and they’re about to get tougher for some of the Japanese company’s U.S. staffers. The drugmaker is cutting its commercial headquarters staff by 16% on Monday, with more layoffs expected in mid-April. The cutbacks are part of a revamp at Daiichi’s U.S. business, based in Parsippany, NJ. The reasons for cutbacks are clear: Daiichi’s exclusivity on the cholesterol drug Welchol expires in June, and a bigger product–the blood pressure drug Benicar–loses its lock on the market next year. That …


UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ #industry #pharmacy

Posted On Apr 18 2017 by

#sankyo pharma # UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ Times have been tough for Daiichi Sankyo, and they’re about to get tougher for some of the Japanese company’s U.S. staffers. The drugmaker is cutting its commercial headquarters staff by 16% on Monday, with more layoffs expected in mid-April. The cutbacks are part of a revamp at Daiichi’s U.S. business, based in Parsippany, NJ. The reasons for cutbacks are clear: Daiichi’s exclusivity on the cholesterol drug Welchol expires in June, and a bigger product–the blood pressure drug Benicar–loses its lock on the market next year. That …


UPDATED: Chicago makes second run at Allergan, J – J, Purdue and others with painkiller lawsuit #esai #pharma

Posted On Apr 13 2017 by

#chicago pharmaceutical companies # UPDATED: Chicago makes second run at Allergan, J J, Purdue and others with painkiller lawsuit Opioid makers thought they had dodged a litigation bullet 6 months ago when a federal judge dismissed a lawsuit by the City of Chicago trying to hold them accountable for an “epidemic” of painkiller, and even heroin, abuse. But the city is being tenacious and has refiled lawsuits claiming 6 drugmakers overstated the claims of the drugs’ benefits while downplaying their risks. The second amended complaint was filed on Thursday in Chicago against Purdue Pharma, Teva Pharmaceutical Industries ($TEVA), Johnson Johnson’s …


UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ #pharma #advertising #agencies

Posted On Apr 9 2017 by

#sankyo pharma # UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ Times have been tough for Daiichi Sankyo, and they’re about to get tougher for some of the Japanese company’s U.S. staffers. The drugmaker is cutting its commercial headquarters staff by 16% on Monday, with more layoffs expected in mid-April. The cutbacks are part of a revamp at Daiichi’s U.S. business, based in Parsippany, NJ. The reasons for cutbacks are clear: Daiichi’s exclusivity on the cholesterol drug Welchol expires in June, and a bigger product–the blood pressure drug Benicar–loses its lock on the market next year. That …


UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ #marksans #pharma

Posted On Mar 17 2017 by

#sankyo pharma # UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ Times have been tough for Daiichi Sankyo, and they’re about to get tougher for some of the Japanese company’s U.S. staffers. The drugmaker is cutting its commercial headquarters staff by 16% on Monday, with more layoffs expected in mid-April. The cutbacks are part of a revamp at Daiichi’s U.S. business, based in Parsippany, NJ. The reasons for cutbacks are clear: Daiichi’s exclusivity on the cholesterol drug Welchol expires in June, and a bigger product–the blood pressure drug Benicar–loses its lock on the market next year. That …


UPDATED: Chicago makes second run at Allergan, J – J, Purdue and others with painkiller lawsuit #pharmaceutical #rep #jobs

Posted On Jan 10 2017 by

#chicago pharmaceutical companies # UPDATED: Chicago makes second run at Allergan, J J, Purdue and others with painkiller lawsuit Opioid makers thought they had dodged a litigation bullet 6 months ago when a federal judge dismissed a lawsuit by the City of Chicago trying to hold them accountable for an “epidemic” of painkiller, and even heroin, abuse. But the city is being tenacious and has refiled lawsuits claiming 6 drugmakers overstated the claims of the drugs’ benefits while downplaying their risks. The second amended complaint was filed on Thursday in Chicago against Purdue Pharma, Teva Pharmaceutical Industries ($TEVA), Johnson Johnson’s …


UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ #kv #pharma

Posted On Dec 7 2016 by

#sankyo pharma # UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ Times have been tough for Daiichi Sankyo, and they’re about to get tougher for some of the Japanese company’s U.S. staffers. The drugmaker is cutting its commercial headquarters staff by 16% on Monday, with more layoffs expected in mid-April. The cutbacks are part of a revamp at Daiichi’s U.S. business, based in Parsippany, NJ. The reasons for cutbacks are clear: Daiichi’s exclusivity on the cholesterol drug Welchol expires in June, and a bigger product–the blood pressure drug Benicar–loses its lock on the market next year. That …


UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ #pharma #jobs

Posted On Nov 1 2016 by

#sankyo pharma # UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ Times have been tough for Daiichi Sankyo, and they’re about to get tougher for some of the Japanese company’s U.S. staffers. The drugmaker is cutting its commercial headquarters staff by 16% on Monday, with more layoffs expected in mid-April. The cutbacks are part of a revamp at Daiichi’s U.S. business, based in Parsippany, NJ. The reasons for cutbacks are clear: Daiichi’s exclusivity on the cholesterol drug Welchol expires in June, and a bigger product–the blood pressure drug Benicar–loses its lock on the market next year. That …


UPDATED: Chicago makes second run at Allergan, J – J, Purdue and others with painkiller lawsuit #otsuka #pharma

Posted On Oct 23 2016 by

#chicago pharmaceutical companies # UPDATED: Chicago makes second run at Allergan, J J, Purdue and others with painkiller lawsuit Opioid makers thought they had dodged a litigation bullet 6 months ago when a federal judge dismissed a lawsuit by the City of Chicago trying to hold them accountable for an “epidemic” of painkiller, and even heroin, abuse. But the city is being tenacious and has refiled lawsuits claiming 6 drugmakers overstated the claims of the drugs’ benefits while downplaying their risks. The second amended complaint was filed on Thursday in Chicago against Purdue Pharma, Teva Pharmaceutical Industries ($TEVA), Johnson Johnson’s …